Sign in

CIK 0001094038

  • Non-accelerated filer
  • Smaller reporting company

Marker Therapeutics, Inc.

Sign in to watch
Ticker
MRKR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880277072
Phone
+1 713-400-6400
Business address
2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
Former names
TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 58 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-11-17 Knobil Katharine Director Grant or award · Stock Option (Right to Buy) +84,411 84,411
2025-11-17 Knobil Katharine Director Grant or award · Stock Option (Right to Buy) +137,330 137,330
2025-11-17 Eansor Norman David Director Grant or award · Stock Option (Right to Buy) +84,411 84,411
2025-11-17 Eansor Norman David Director Grant or award · Stock Option (Right to Buy) +137,330 137,330
2025-11-17 ELMS STEVE Director Grant or award · Stock Option (right to buy) +84,411 84,411
2025-11-17 ELMS STEVE Director Grant or award · Stock Option (right to buy) +137,330 137,330
2025-10-31 Corzo Kathryn Penkus Director Grant or award · Stock Option (Right to Buy) +147,611 147,611
2025-10-31 Vera Juan Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +250,000 250,000
2025-02-12 ELMS STEVE Director Grant or award · Stock Option (right to buy) +30,000 30,000
2025-02-12 Knobil Katharine Director Grant or award · Stock Option (right to buy) +30,000 30,000
2025-02-12 Eansor Norman David Director Grant or award · Stock Option (right to buy) +30,000 30,000
2025-02-12 Vera Juan President and CEO Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2024-12-23 ELMS STEVE Director Purchase +11,085 $3.20 $35K 325,370
2024-12-23 New Enterprise Associates 16, L.P. 10% owner Purchase +554,250 $3.20 $1.8M 1,625,678
2023-06-06 Eansor Norman David Director Grant or award · Stock Option (right to buy) +8,000 8,000
2023-06-06 Knobil Katharine Director Grant or award · Stock Option (right to buy) +8,000 8,000
2023-06-06 Wilson John Robert Director Grant or award · Stock Option (right to buy) +8,000 8,000
2023-06-06 ELMS STEVE Director Grant or award · Stock Option (right to buy) +8,000 8,000
2023-05-10 Vera Juan President and CEO Grant or award · Employee Stock Option (right to buy) +100,000 100,000
2023-02-27 Hoang Tsvetelina P VP, Research and Development Grant or award · Employee Stock Option (right to buy) +33,159 33,159

Page 1 of 6 · 119 trades